Emv Capital (EMVC) RNS Announcements

Add to Alert list
Date Time Source Announcement
25 Apr 2022 02:05 PM
RNS
Second Price Monitoring Extn
25 Apr 2022 02:00 PM
RNS
Price Monitoring Extension
25 Apr 2022 11:05 AM
RNS
Second Price Monitoring Extn
25 Apr 2022 11:00 AM
RNS
Price Monitoring Extension
31 Mar 2022 01:24 PM
RNS
PDS Provides Business Update & Full-Year Results
04 Mar 2022 07:30 AM
RNS
Publication of Shareholder Newsletter
24 Feb 2022 04:45 PM
RNS
PDS Announces Preliminary Safety Data on PDS0101
15 Feb 2022 02:32 PM
RNS
PDS Clinical Trial with Mayo Clinic
02 Feb 2022 03:00 PM
RNS
PDS Phase 2 Trial Update
28 Jan 2022 08:45 AM
RNS
PDS Announces Preclinical Data for PDS0202 Vaccine
18 Jan 2022 07:00 AM
RNS
Holding(s) in Company
10 Jan 2022 02:20 PM
RNS
PDS Granted Novel HPV16 Immunotherapy Patent
10 Jan 2022 07:00 AM
RNS
ProAxsis CEO End of Year Update
29 Dec 2021 08:47 AM
RNS
Issue of Equity
21 Dec 2021 01:59 PM
RNS
TR-1: Form for notification of major holdings
21 Dec 2021 07:00 AM
RNS
Q-Bot Investment and Share Acquisition
20 Dec 2021 07:00 AM
RNS
Acquisition of majority stake in Cetromed
13 Dec 2021 07:00 AM
RNS
Martlet Capital Update
06 Dec 2021 02:53 PM
RNS
PDS Phase 2 Clinical Trial Update
26 Nov 2021 07:00 AM
RNS
$1million investment in portfolio company, EpiBone
10 Nov 2021 01:58 PM
RNS
PDS Reports Q3 2021 Results & Business Update
04 Nov 2021 07:00 AM
RNS
Sofant Signs EUR7.3m ESA Contract
01 Nov 2021 02:16 PM
RNS
PDS to License Novel Proteins for Flu Vaccine
26 Oct 2021 07:00 AM
RNS
EMV Capital Participates in £843k Sofant Funding
22 Oct 2021 11:18 AM
RNS
ProAxsis announces the approval of a key US patent
22 Oct 2021 09:04 AM
RNS
Holding(s) in Company
21 Oct 2021 04:40 PM
RNS
Second Price Monitoring Extn
21 Oct 2021 04:35 PM
RNS
Price Monitoring Extension
21 Oct 2021 02:17 PM
RNS
PDS Phase 2 Clinical Trial Update
05 Oct 2021 07:00 AM
RNS
PDS Phase 2 Clinical Trial Update
04 Oct 2021 07:00 AM
RNS
Investor Presentations
30 Sep 2021 10:22 AM
RNS
Holding(s) in Company
29 Sep 2021 07:00 AM
RNS
Grant of Options to Directors
29 Sep 2021 07:00 AM
RNS
Interim Results
20 Sep 2021 07:00 AM
RNS
Notice of Results and Analyst Briefing
16 Sep 2021 07:00 AM
RNS
Investment in Martlet Capital Limited
09 Aug 2021 05:59 PM
RNS
Holding(s) in Company
30 Jul 2021 09:12 AM
RNS
Holding(s) in Company
26 Jul 2021 04:25 PM
RNS
Holding(s) in Company
22 Jul 2021 04:29 PM
RNS
Holding(s) in Company
20 Jul 2021 02:05 PM
RNS
Second Price Monitoring Extn
20 Jul 2021 02:00 PM
RNS
Price Monitoring Extension
16 Jul 2021 10:35 AM
RNS
Director/PDMR Shareholding
01 Jul 2021 12:08 PM
RNS
Holding(s) in Company
30 Jun 2021 03:42 PM
RNS
Holding(s) in Company
30 Jun 2021 10:29 AM
RNS
Holding(s) in Company
30 Jun 2021 10:27 AM
RNS
Holding(s) in Company
28 Jun 2021 03:18 PM
RNS
Result of General Meeting, TVR & PDMR Dealings
22 Jun 2021 07:00 AM
RNS
PDS Announces Closing of c. $52m Public Offering
16 Jun 2021 07:00 AM
RNS
NSCI Participates in $45m PDS Equity Issue
UK 100